Results 41 to 50 of about 20,649 (250)

Prevalence of biocide resistance genes and chlorhexidine and mupirocin non-susceptibility in Portuguese hospitals during a 31-year period (1985–2016)

Journal of Global Antimicrobial Resistance, 2021
Objectives: Methicillin-resistantStaphylococcus aureus (MRSA) remains a major human pathogen. MRSA decolonisation strategies frequently combine chlorhexidine baths and mupirocin nasal ointment.
Teresa Conceição, Hermínia de Lencastre, Marta Aires-de-Sousa   +2 more
doaj   +1 more source

Prevalence of qacA/B genes and mupirocin resistance among methicillin-resistant Staphylococcus aureus (MRSA) isolates in the setting of chlorhexidine bathing without mupirocin [PDF]

, 2016
OBJECTIVE: We aimed to determine the frequency of qacA/B chlorhexidine tolerance genes and high-level mupirocin resistance among MRSA isolates before and after the introduction of a chlorhexidine (CHG) daily bathing intervention in a surgical intensive ...
Bommarito, Kerry M, Burnham, Carey-Ann D, Kennedy, Colleen R, Mazuski, John E, Munigala, Satish, Prager, Martin, Wallace, Meghan A, Warren, David K   +7 more
core   +2 more sources

Susceptibility to chlorhexidine and mupirocin among methicillin-resistant Staphylococcus aureus clinical isolates from a teaching hospital

Revista do Instituto de Medicina Tropical de São Paulo, 2021
Despite the widespread use of chlorhexidine (CHX) to prevent infection, data regarding the in vitro action of CHX against methicillin-resistant Staphylococcus aureus (MRSA) are limited.
Taniela Marli Bes, Lauro Perdigão-Neto, Roberta Ruedas Martins, Inneke Heijden, Priscila de Arruda Trindade, Gaspar Camilo, Debora Satie Nagano, Diego Mongelos, Ana Paula Marchi, Mariama Tomaz, Larissa Marques de Oliveira, Flavia Rossi, Anna Sara Levin, Silvia Figueiredo Costa   +13 more
doaj   +1 more source

Mupirocin Resistance in Staphylococcus aureus Isolates among Patients in a Tertiary Care Hospital in Central Kerala: A Cross-sectional Study [PDF]

National Journal of Laboratory Medicine
Introduction: Methicillin-Resistant Staphylococcus aureus (MRSA) is a major cause of hospital-acquired infections, with mupirocin being a key agent for decolonisation. However, increasing resistance to mupirocin threatens its effectiveness. Understanding
Pk Sreekumary, Vipin Sam Alexander, Dani Kochuplapparambil Thampi   +2 more
doaj   +1 more source

Transfer of antibiotic resistance in Staphylococcus aureus [PDF]

, 2017
Staphylococcus aureus is a serious human pathogen with remarkable adaptive powers. Antibiotic-resistant clones rapidly emerge mainly by acquisition of antibiotic-resistance genes from other S. aureus strains or even from other genera.
Haaber, Jakob, Ingmer, Hanne, Penadés, José R.   +2 more
core   +1 more source

In vitro activity and resistance rates of topical antimicrobials fusidic acid, mupirocin and ozenoxacin against skin and soft tissue infection pathogens obtained across Canada (CANWARD 2007-18).

Journal of Antimicrobial Chemotherapy, 2021
BACKGROUND Current antimicrobial susceptibility/resistance data versus skin and soft tissue infection (SSTI) pathogens help to guide empirical treatment using topical antimicrobials.
G. Zhanel, H. Adam, M. Baxter, P. Lagacé-Wiens, J. Karlowsky   +4 more
semanticscholar   +1 more source

Effective decolonization strategy for mupirocin-resistant Staphylococcus aureus by TPGS-modified mupirocin-silver complex

Materials Today Bio, 2023
The widespread utilization of mupirocin to treat methicillin-resistant Staphylococcus aureus (MRSA)-caused infectious diseases has led to the emergence of mupirocin-resistant Staphylococcus aureus (MuRSA), posing a serious global medical threat. In order
Ming-Chen Sun, Ying-Fang Chen, Di Liu, Xiao-Ling Xu, Yu-Chan You, Wei Lu, Yun-Juan Shi, Ming-Yang Ren, Yi-Bin Fan, Yong-Zhong Du, Xiao-Hua Tao   +10 more
doaj   +1 more source

The small quinolone derived compound HT61 enhances the effect of tobramycin against Pseudomonas aeruginosa in vitro and in vivo. [PDF]

, 2020
HT61 is a small quinolone-derived compound previously demonstrated to exhibit bactericidal activity against gram-positive bacteria including methicillin-susceptible Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA). When
Amison, RT, Bruce, KD, Coates, A, Faure, M-E, Hu, Y, O'Shaughnessy, BG, Page, CP   +6 more
core   +1 more source

Mupirocin prophylaxis against nosocomial Staphylococcus aureus infections in nonsurgical patients: a randomized study [PDF]

, 2004
BACKGROUND: Staphylococcus aureus nasal carriage is a major risk factor for nosocomial S. aureus infection. Studies show that intranasal mupirocin can prevent nosocomial surgical site infections. No data are available on the efficacy of
Keulen, P.H.J. (Peter) van, Kluytmans, J.A.J.W. (Jan), Meester, M.H.M. (Marlene), Ott, A. (Alewijn), Vandenbroucke-Grauls, C.M.J.E. (Christina), Verbrugh, H.A. (Henri), Vos, M.C. (Margreet), Voss, A. (Andreas), Wertheim, H.F.L. (Heiman)   +8 more
core   +4 more sources

Phenotypic and molecular characterization of Staphylococcus aureus isolates expressing low- and high-level mupirocin resistance in Nigeria and South Africa

BMC Infectious Diseases, 2009
Background Mupirocin is a topical antimicrobial agent which is used for the treatment of skin and postoperative wound infections, and the prevention of nasal carriage of methicillin-resistant Staphylococcus aureus (MRSA).
Udo Edet E, Shittu Adebayo O, Lin Johnson   +2 more
doaj   +1 more source